News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
251,340 Results
Type
Article (7672)
Company Profile (15)
Press Release (243652)
Multimedia
Podcasts (12)
Webinars (3)
Section
Business (74862)
Career Advice (315)
Deals (14830)
Drug Delivery (48)
Drug Development (36981)
Employer Resources (24)
FDA (6537)
Job Trends (4941)
News (122410)
Policy (11710)
Tag
2027 BioCapital Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
40 Under 40 (1)
Academia (617)
Accelerated approval (37)
ADA (14)
Adcomms (12)
Allergies (102)
Alliances (14870)
ALS (118)
Alzheimer's disease (845)
Antibody-drug conjugate (ADC) (384)
Approvals (7088)
Artificial intelligence (348)
ASCO (182)
Autoimmune disease (273)
Automation (23)
Bankruptcy (150)
Belgium (13)
Best Places to Work (4617)
BIO (28)
Biologics (29)
BIOSECURE Act (2)
Biosimilars (104)
BioSpace Insights (42)
Biotechnology (19)
Bispecific (13)
Bladder cancer (160)
Brain cancer (63)
Breast cancer (408)
Cancer (4102)
Cardiovascular disease (268)
Career advice (290)
Career pathing (16)
CAR-T (260)
CDC (14)
CDMO (42)
Celiac Disease (5)
Cell therapy (590)
Cervical cancer (41)
Clinical research (35568)
Collaboration (1026)
Commercialization (20)
Compensation (291)
Complete response letters (43)
COVID-19 (824)
CRISPR (54)
C-suite (596)
Cystic fibrosis (80)
Data (6359)
Decentralized trials (1)
Denatured (7)
Depression (97)
Dermatology (93)
Diabetes (288)
Diagnostics (2648)
Digital health (26)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (160)
Drug pricing (69)
Drug shortages (19)
Duchenne muscular dystrophy (176)
Earnings (37625)
Editorial (24)
Employer branding (1)
Employer resources (21)
Events (35687)
Executive appointments (462)
Eye disease (6)
FDA (9388)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (17)
Frontotemporal dementia (28)
Funding (854)
Gene editing (122)
Generative AI (31)
Gene therapy (394)
GLP-1 (357)
Government (1358)
Grass and pollen (2)
Guidances (317)
Healthcare (6286)
Hematology (112)
HIV (69)
Huntington's disease (27)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (85)
Immunology and inflammation (113)
Immuno-oncology (74)
Indications (158)
Infectious disease (1003)
Inflammatory bowel disease (118)
Inflation Reduction Act (6)
Influenza (60)
Intellectual property (238)
Interviews (49)
IPO (8142)
IRA (21)
Job creations (573)
Job search strategy (229)
JPM (12)
Kidney cancer (20)
Kidney disease (59)
Labor market (20)
Layoffs (55)
Leadership (14)
Legal (2116)
Licensing (35)
Liver cancer (62)
Longevity (16)
Lung cancer (557)
Lung diease (13)
Lymphoma (331)
Machine learning (28)
Management (8)
Manufacturing (521)
Marketing (15)
MASH (138)
Medical affairs (2)
Medical device (4946)
Medtech (5082)
Mergers & acquisitions (7620)
Metabolic disorders (749)
mRNA (82)
Multiple sclerosis (126)
Multispecific (1)
NASH (9)
Netherlands (11)
Neurodegenerative disease (210)
Neuropsychiatric disorders (54)
Neuroscience (1741)
NextGen: Class of 2026 (1518)
Non-profit (749)
Now hiring (2)
Obesity (305)
Opinion (140)
Ovarian cancer (197)
Pain (154)
Pancreatic cancer (283)
Parkinson's disease (184)
Partnered (15)
Patents (456)
Patient advocacy (1)
Patient recruitment (580)
Patient selection (44)
Peanut (22)
People (15972)
Peptides (10)
Pharmaceutical (6)
Pharmacy benefit managers (12)
Phase 1 (11395)
Phase 2 (15702)
Phase 3 (11727)
Pipeline (8243)
Policy (95)
Postmarket research (796)
Preclinical (4198)
Press Release (9)
Prostate cancer (210)
Psychedelics (20)
Radioligand (1)
Radiopharmaceuticals (184)
Rare diseases (671)
Real estate (1025)
Recruiting (8)
Regenerative medicine (9)
Regulatory (11741)
Reports (26)
Research institute (556)
Resumes & cover letters (41)
Rett syndrome (41)
RNA editing (13)
RSV (40)
Schizophrenia (111)
Series A (142)
Series B (105)
Service/supplier (1)
Sickle cell disease (65)
Special edition (2)
Spinal muscular atrophy (43)
Sponsored (22)
Startups (704)
Stem cells (1)
Stomach cancer (6)
Substance use disorders (11)
Supply chain (50)
Tariffs (15)
The Weekly (4)
Vaccines (386)
Venture capital (34)
Weight loss (155)
Wet AMD (2)
Women's health (73)
Worklife (5)
Date
Last 7 days (297)
Last 30 days (1231)
Last 365 days (16014)
2026 (12676)
2025 (15068)
2024 (16931)
2023 (19120)
2022 (22255)
2021 (23656)
2020 (21822)
2019 (14484)
2018 (10664)
2017 (11474)
2016 (9549)
2015 (11754)
2014 (8116)
2013 (5882)
2012 (6054)
2011 (6763)
2010 (6219)
Location
Africa (194)
Alabama (44)
Alaska (2)
Arizona (111)
Arkansas (4)
Asia (19004)
Australia (5220)
California (8299)
Canada (2563)
China (909)
Colorado (330)
Connecticut (435)
Delaware (191)
Europe (31307)
Florida (1316)
Georgia (158)
Hawaii (1)
Idaho (7)
Illinois (636)
India (109)
Indiana (301)
Iowa (4)
Japan (390)
Kansas (35)
Kentucky (16)
Louisiana (21)
Maine (52)
Maryland (865)
Massachusetts (5531)
Michigan (145)
Minnesota (294)
Missouri (86)
Montana (12)
Nebraska (9)
Nevada (128)
New Hampshire (47)
New Jersey (2541)
New Mexico (7)
New York (2326)
North Carolina (852)
North Dakota (2)
Northern California (4293)
Ohio (177)
Oklahoma (4)
Oregon (11)
Pennsylvania (1535)
Puerto Rico (15)
Rhode Island (18)
South America (310)
South Carolina (64)
Southern California (3414)
Tennessee (113)
Texas (1359)
United States (28193)
Utah (203)
Vermont (1)
Virginia (220)
Washington D.C. (21)
Washington State (711)
West Virginia (2)
Wisconsin (36)
Wyoming (1)
251,340 Results for "bionomics limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Bionomics Limited Announces Private Placement of up to $70.0 Million
Bionomics Limited announced it has entered into a securities purchase agreement with an institutional accredited investor to purchase American Depository Shares and accompanying warrants in a three-tranche private placement.
May 31, 2024
·
7 min read
Press Releases
Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
August 18, 2026
·
3 min read
Genetown
Bionomics to Present at the 2024 BIO CEO & Investor Conference
Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) today announced that it will be presenting at the 2024 BIO CEO & Investor Conference taking place February 26-27, 2024 in New York, NY.
February 22, 2024
·
3 min read
Press Releases
Bionomics Limited announces intention to re-domicile to the United States
October 1, 2024
·
9 min read
Press Releases
Kazia Therapeutics Limited Announces Proposed Public Offering
August 27, 2026
·
6 min read
Press Releases
Cuprina Holdings (Cayman) Limited Announces Closing of Public Offering
September 18, 2026
·
5 min read
Genetown
Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
Bionomics Limited announced that Spyridon “Spyros” Papapetropoulos, M.D., PhD, President and Chief Executive Officer of Bionomics will be giving an oral presentation and presenting two posters about BNC210 as a potential treatment for social anxiety disorder and post-traumatic stress disorder at the 2024 American Society of Clinical Psychopharmacology Annual Meeting taking place May 28 – 31 in Miami Beach, Florida.
May 20, 2024
·
4 min read
Press Releases
CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
October 12, 2026
·
4 min read
Bionomics Limited to Participate in Upcoming November 2022 Investor Conferences
Bionomics Limited announced that it will participate in the following upcoming investor conferences in November.
November 2, 2022
·
1 min read
Genetown
Bionomics Provides a Review of 2023 and of 2024 Plans
Bionomics Limited, a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system disorders with high unmet medical need, provided a 2023 review and its outlook for 2024.
January 22, 2024
·
8 min read
1 of 25,134
Next
